# Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression

> **NCT05058287** · PHASE3 · RECRUITING · sponsor: **Hospital for Special Surgery, New York** · enrollment: 150 (estimated)

## Conditions studied

- Opioid Use
- Lumbar Spinal Stenosis
- Pain, Postoperative
- Pain, Back

## Interventions

- **DRUG:** Depo-Medrol 40Mg/Ml Suspension for Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05058287
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-05
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05058287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05058287, "Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05058287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*